Evidence-Based Medical News

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Text Size

Log in / Sign up

fluconazole

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of fluconazole

32 trials tracked of fluconazole: 13 in phase 3 or 4 and 6 with published results. The most-cited published study has 108 citations.

32Trials tracked

13Phase 3 & 4

0Recruiting

6With published results

Phase distribution

Phase 4 3 Phase 3 10 Phase 2 10 Phase 1 8 Other / NA 1

Phase 3 Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Completed · 108 cited
Phase 3 Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Completed · 39 cited
Phase 3 Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis Completed · 36 cited
Phase 4 Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis Completed · 35 cited
Phase 4 Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis Completed · 23 cited
Phase 3 Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis Completed · 16 cited

Show 26 more trials

Phase 4 Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients Completed
Phase 3 POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED) Completed
Phase 3 Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight Completed
Phase 3 Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Completed
Phase 3 The Study Of Fluconazole For Vulvovaginal Candidiasis Completed
Phase 3 Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study Completed
Phase 3 Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED) Completed
Phase 2 Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis Completed
Phase 2 Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder Completed
Phase 2 A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) Completed
Phase 2 High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals Completed
Phase 2 CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension Completed
Phase 2 Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) Completed
Phase 2 Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease Completed
Phase 2 Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease Completed
Phase 2 Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis Completed
Phase 2 Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis Completed
Phase 1 Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients Completed
Phase 1 Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors Completed
Phase 1 Relative Bioavailability of Olodaterol and Fluconazole Completed
Phase 1 A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects Completed
Phase 1 A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors Completed
Phase 1 Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies Completed
Phase 1 A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood Completed
Phase 1 A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants Completed
N/A Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication Completed

Showing the 32 most-cited and recently-updated of 32 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.